Rhoen-Klinikum to Sell Hospitals to Fresenius SE for $4 Billion

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Germany’s Rhoen-Klinikum is to sell most of its hospitals to rival Fresenius SE for 3.07 billion euros ($4.1 billion), in an attempt by Rhoen’s founder, Eugen Muench, to outflank opponents to an outright sale of the company. The sale comes exactly 12 months after Fresenius dropped plans to buy all of Rhoen for 3.1 billion euros after an industry rival and service supplier bought blocking stakes in Rhoen. The 43 hospitals and 15 outpatient facilities now being sold account for about two thirds of Rhoen’s revenues, with mainly specialized clinics and university teaching hospitals remaining with Rhoen.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC